The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review

Shaney L. Barratt, Richard Davis, Charles Sharp, John D. Pauling

Source: ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020
Journal Issue: July

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Shaney L. Barratt, Richard Davis, Charles Sharp, John D. Pauling. The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review. ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2018 – PG16 Advanced cardiopulmonary exercise testing
Year: 2018


The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2019 – PG3 Advanced cardiopulmonary exercise testing
Year: 2019


The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
Year: 2011


Exercise testing in the prognostic evaluation of patients with lung and heart diseases
Source: Eur Respir Monogr 2018; 80: 222-234
Year: 2018


Exercise testing in the prognostic evaluation of patients with lung and heart diseases
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=195
Year: 2007

The prognostic significance of cardiopulmonary exercise in IPF
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007


Value of cardiopulmonary exercise testing in interstitial lung diseases
Source: International Congress 2018 – New methods and concepts in exercise testing
Year: 2018

Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing
Source: Eur Respir Rev 2017; 26: 160099
Year: 2017



ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases
Source: Eur Respir Rev, 28 (154) 180101; 10.1183/16000617.0101-2018
Year: 2019



Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency
Source: Eur Respir Rev, 30 (162) 200355; 10.1183/16000617.0355-2020
Year: 2021



Chest wall volumes during constant compared to incremental cycle ergometer tests in chronic obstructive pulmonary disease (COPD) patients: A systematic review and meta-analysis
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015

Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature
Source: Eur Respir J 2009; 33: 1206-1215
Year: 2009



Application of a predictive formula for hypoxic challenge testing in patients with interstitial lung disease
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

The value of cardiopulmonary exercise testing in sarcoidosis
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015

Standardisation of cardiopulmonary exercise testing in chronic lung diseases: summary of key findings from the ERS task force
Source: Eur Respir J, 54 (6) 1901441; 10.1183/13993003.01441-2019
Year: 2019



Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty
Source: Eur Respir J 2016; 48: 1274-1277
Year: 2016


Concurrent validity among three field tests and the cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis.
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Physical activity and mortality risk in people with interstitial lung disease: a systematic review and meta-analysis
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021